1. Home
  2. RGEN vs XP Comparison

RGEN vs XP Comparison

Compare RGEN & XP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • XP
  • Stock Information
  • Founded
  • RGEN 1981
  • XP 2001
  • Country
  • RGEN United States
  • XP Cayman Islands
  • Employees
  • RGEN N/A
  • XP N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • XP Investment Bankers/Brokers/Service
  • Sector
  • RGEN Health Care
  • XP Finance
  • Exchange
  • RGEN Nasdaq
  • XP Nasdaq
  • Market Cap
  • RGEN 8.0B
  • XP 7.5B
  • IPO Year
  • RGEN N/A
  • XP 2019
  • Fundamental
  • Price
  • RGEN $120.21
  • XP $18.65
  • Analyst Decision
  • RGEN Buy
  • XP Buy
  • Analyst Count
  • RGEN 12
  • XP 6
  • Target Price
  • RGEN $172.67
  • XP $22.00
  • AVG Volume (30 Days)
  • RGEN 811.4K
  • XP 8.3M
  • Earning Date
  • RGEN 04-29-2025
  • XP 05-20-2025
  • Dividend Yield
  • RGEN N/A
  • XP 3.47%
  • EPS Growth
  • RGEN N/A
  • XP 16.66
  • EPS
  • RGEN N/A
  • XP 1.53
  • Revenue
  • RGEN $650,429,000.00
  • XP $2,886,079,350.00
  • Revenue This Year
  • RGEN $13.93
  • XP $19.79
  • Revenue Next Year
  • RGEN $14.35
  • XP $12.65
  • P/E Ratio
  • RGEN N/A
  • XP $12.12
  • Revenue Growth
  • RGEN 4.88
  • XP 9.27
  • 52 Week Low
  • RGEN $102.97
  • XP $10.82
  • 52 Week High
  • RGEN $182.52
  • XP $21.82
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 39.75
  • XP 73.39
  • Support Level
  • RGEN $120.11
  • XP $18.30
  • Resistance Level
  • RGEN $129.42
  • XP $19.10
  • Average True Range (ATR)
  • RGEN 6.22
  • XP 0.56
  • MACD
  • RGEN -0.97
  • XP 0.11
  • Stochastic Oscillator
  • RGEN 0.43
  • XP 72.52

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About XP XP Inc.

XP Inc is a Cayman Island-based technology-driven financial services platform. It is a provider of low-fee financial products and services in Brazil. The company evaluates its business through a single segment such as monitoring operations, making decisions on fund allocation, and evaluating the performance. It generates revenue through the Brokerage commission.

Share on Social Networks: